{"id":755143,"date":"2026-06-23T05:35:24","date_gmt":"2026-06-23T05:35:24","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/755143\/"},"modified":"2026-06-23T05:35:24","modified_gmt":"2026-06-23T05:35:24","slug":"colon-cancers-immune-system-invisibility-cloak-may-finally-be-exposed","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/755143\/","title":{"rendered":"Colon Cancer\u2019s Immune System \u201cInvisibility Cloak\u201d May Finally Be Exposed"},"content":{"rendered":"<p>Immunotherapy works for roughly 15% of colon cancer patients. The other 85% get nothing. That\u2019s not a rounding error \u2014 it\u2019s a crisis. With an estimated <a href=\"https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/colorectal\/statistics\" target=\"_blank\" rel=\"noopener nofollow\">25,300 Canadians<\/a> facing a colorectal <a href=\"https:\/\/www.gadgetreview.com\/man-uses-chatgpt-to-design-cancer-vaccine-that-saved-his-dogs-life\" rel=\"nofollow noopener\" target=\"_blank\">cancer<\/a> diagnosis this year, and incidence climbing sharply in people under 50, the urgency is real. A team at the <a href=\"https:\/\/charbonneau.ucalgary.ca\/\" target=\"_blank\" rel=\"noopener noreferrer nofollow\">University of Calgary<\/a> led by Dr. Arshad Ayyaz has published research in Cell Reports Medicine identifying why most of these tumours dodge the immune system entirely. The fix, at least in mice: knock out one gene, and the cancer loses its ability to hide. Tumours didn\u2019t just shrink. They were eradicated.<\/p>\n<p>Why Immunotherapy Keeps Failing Colon Cancer Patients<\/p>\n<p>Most colon tumours don\u2019t overpower the immune system \u2014 they simply vanish from its radar.<\/p>\n<p><a href=\"https:\/\/www.cancerresearch.org\/immunotherapy-by-cancer-type?campaign=784691\" target=\"_blank\" rel=\"noopener nofollow\">Checkpoint inhibitors<\/a> like Keytruda and Opdivo work by removing the brakes on your immune system so it can attack cancer. Straightforward enough. But most colon tumours play a different game. Ayyaz\u2019s team discovered that resistant tumours contain a previously unrecognized cell type that secretes a specific protein \u2014 one that essentially tricks the immune system into believing nothing is wrong. The tumour wraps itself in a molecular invisibility cloak, and the immune system walks right past.<\/p>\n<p>What the UCalgary team found:<\/p>\n<p>A distinct cancer cell type in resistant tumours produces the cloaking proteinThat protein traces back to a single geneGene-editing techniques knocked that gene out completelyTumours became visible to the immune systemCombined with immunotherapy: 100% tumour eradication in mouse models; even without drugs, tumours shrank on their own<\/p>\n<p>The result wasn\u2019t subtle. Think less \u201cfinding a new weapon\u201d and more pulling the stealth coating off a fighter jet \u2014 the radar was working the whole time.<\/p>\n<p>\u201cI couldn\u2019t believe it at first\u2026 By just knocking out one gene, the results are black and white.\u201d \u2014 <a href=\"https:\/\/ucalgary.ca\/news\/ucalgary-study-tears-colon-cancers-invisibility-cloak\" target=\"_blank\" rel=\"noopener nofollow\">Dr. Arshad Ayyaz<\/a>, University of Calgary<\/p>\n<p>Promising in Mice. The Hard Part Is Still Ahead.<\/p>\n<p>A <a href=\"https:\/\/www.gadgetreview.com\/german-scientists-revive-frozen-brain-tissue-after-week-long-deep-freeze\" rel=\"nofollow noopener\" target=\"_blank\">striking preclinical result<\/a> is only the first step on a long road to human treatment.<\/p>\n<p>A 100% eradication rate in mice sounds extraordinary. But mice aren\u2019t humans, and the distance between a preclinical knockout and a bedside treatment remains vast. Safe delivery systems need development. Specificity must be proven \u2014 disabling the cloak in cancer cells without triggering immune chaos in healthy tissue. Then comes the full gauntlet of phase I through III trials.<\/p>\n<p>\u201cIt is very fundamental research that is still quite some distance away from clinical settings.\u201d \u2014 <a href=\"https:\/\/ucalgary.ca\/news\/ucalgary-study-tears-colon-cancers-invisibility-cloak\" target=\"_blank\" rel=\"noopener nofollow\">Dr. Arshad Ayyaz<\/a>, University of Calgary<\/p>\n<p>The broader signal matters, though. Ayyaz suspects a similar cloaking mechanism operates in pancreatic and lung cancers \u2014 tumours where immunotherapy also largely fails. Across the CRISPR-era research landscape, the paradigm is shifting: less \u201cbuild a stronger army,\u201d more \u201cstrip away the enemy\u2019s camouflage.\u201d<\/p>\n<p>For younger patients diagnosed at advanced stages \u2014 often after the <a href=\"https:\/\/www.gadgetreview.com\/how-one-scientist-turned-ultrasound-into-a-cancer-tumor-destroyer\" rel=\"nofollow noopener\" target=\"_blank\">cancer<\/a> has already spread \u2014 current options remain brutally limited. This discovery doesn\u2019t change that today. But it names the problem with uncommon precision, and in cancer research, that\u2019s where every solution starts.<\/p>\n","protected":false},"excerpt":{"rendered":"Immunotherapy works for roughly 15% of colon cancer patients. The other 85% get nothing. That\u2019s not a rounding&hellip;\n","protected":false},"author":2,"featured_media":755144,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[49,48,84],"class_list":["post-755143","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-ca","tag-canada","tag-health"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/755143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=755143"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/755143\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/755144"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=755143"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=755143"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=755143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}